EMcision
London
About EMcision
EMcision is a medical device company committed to improving the lives of cancer patients. It provides Habib EndoHPB, an endoscopic bipolar RF probe developed to ablate tissue in the gastro-intestinal tract; Habib Endoblate, a bipolar RF probe that is particularly effective for performing endoluminal ablation of gastrointestinal tumours that are not suitable for surgical resection; Habib VesCoag, an endovascular RF catheter that is particularly effective for precise vascular occlusion.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Website: emcision.com
- Phone: +44 1462 423 594
Social Profiles
Canonical: https://fsome.com/organization/emcision-1603141 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.